• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4

CATEGORIES

  • 14
  • 10
  • 10
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

4
5
38
43

PUBLISHED

1
8
35
43

PRODUCT TYPE

38
5

Search "Athersys, Inc.-Therapeutic Competitors" returned 43 results.

PRODUCT TITLE

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

June 2014
FROM

Global Stem Cell and Advanced Technologies Market

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies The benefits of stem cell therapy are attracting an increasing number of patients The product...

November 2009
FROM

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D

GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government...

November 2011
FROM

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014’, provides...

May 2014
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides an overview of the...

October 2014
FROM
Bulk Paclitaxel - Global Strategic Business Report Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

This report analyzes the worldwide markets for Bulk Paclitaxel in kilograms and US$ Million. The report provides separate comprehensive analytics for the US, and Rest of World. Annual forecasts are...

October 2008
FROM

RTI Biologics, Inc. Market Share Analysis

RTI Biologics, Inc. Market Share Analysis Summary Our new report, “RTI Biologics, Inc. Market Share Analysis” provides in-depth information on RTI Biologics, Inc.’s market position in the orthobiologics...

October 2012
FROM

Myelodysplastic Syndrome - Pipeline Review, H1 2014

Myelodysplastic Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2014’, provides an overview of the Myelodysplastic Syndrome’s therapeutic...

February 2014
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014’, provides an overview of the Hematopoietic Stem...

October 2014
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014’, provides an overview of the...

April 2014
FROM

Ischemia - Pipeline Review, H2 2014

Ischemia - Pipeline Review, H2 2014 Summary This, ‘Ischemia - Pipeline Review, H2 2014’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity

GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies,...

December 2012
FROM

Spinal Cord Injury - Pipeline Review, H1 2014

Spinal Cord Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Spinal Cord Injury - Pipeline Review, H1 2014’, provides an overview of the Spinal Cord Injury’s therapeutic pipeline. This...

February 2014
FROM

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

October 2014
FROM

Traumatic Brain Injury - Pipeline Review, H1 2014

Traumatic Brain Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H1 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic...

April 2014
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2014

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2014’, provides an overview of the Graft Versus...

March 2014
FROM

Critical Limb Ischemia - Pipeline Review, H2 2014

Critical Limb Ischemia - Pipeline Review, H2 2014 Summary This, ‘Critical Limb Ischemia - Pipeline Review, H2 2014’, provides an overview of the Critical Limb Ischemia’s therapeutic pipeline. This...

November 2014
FROM

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014 Summary This, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014’, provides an overview of the Congestive Heart...

October 2014
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

September 2014
FROM
Loading Indicator

Our Clients

Hexcel Corporation Harrods Ltd. Bayer AG Google, Inc. Boeing Company Harley Davidson Motor Company SwissCom AG